Private Equity

Updated:

Shanghai Healthcare Capital

Shanghai Healthcare Capital is a venture capital firm that invests in healthcare opportunities. The firm has made 5 investments, including a Seed VC in...

Shanghai Healthcare Capital logo

Shanghai Healthcare Capital

Shanghai Healthcare Capital is a venture capital firm that invests in healthcare opportunities. The firm has made 5 investments, including a Seed VC in Fortitude Biomedicines on January 26, 2026. Shanghai Healthcare Capital has a single portfolio exit, ArriVent Biopharma, which occurred on January 26, 2024.

General information

Firm type

Private Equity

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Sector focus

Healthcare ServicesDigital HealthMedical DevicesAgriTech & FoodTech

Frequently asked questions

What investment stages does Shanghai Healthcare Capital target?

The firm targets early-stage seed and start-up rounds, alongside expansion and late-stage growth equity. It also pursues general venture strategies. This stage-agnostic approach within healthcare allows participation across a company's lifecycle, from preclinical biotech to commercial-stage medical device manufacturers.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Shanghai Private Equity profiles